Loading...
Keywords
Last Name
Institution

Matthew McLaughlin

Concepts (100)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Palsy
6
2022
13
4.880
Why?
Baclofen
4
2020
8
2.480
Why?
Pharmacogenetics
3
2019
112
1.500
Why?
Dose-Response Relationship, Drug
3
2020
99
1.130
Why?
Humans
17
2022
5729
1.120
Why?
Child
11
2022
2689
1.110
Why?
Muscle Relaxants, Central
2
2020
6
1.040
Why?
Pandemics
2
2020
41
1.000
Why?
Alphapapillomavirus
1
2022
1
0.970
Why?
Papillomavirus Infections
1
2022
6
0.960
Why?
Papillomavirus Vaccines
1
2022
7
0.950
Why?
Spinal Dysraphism
1
2021
5
0.900
Why?
Medical Informatics
1
2021
6
0.890
Why?
Neuromuscular Agents
1
2020
1
0.840
Why?
Rehabilitation
1
2020
1
0.840
Why?
Botulinum Toxins, Type A
1
2020
1
0.840
Why?
Drug Discovery
1
2020
4
0.840
Why?
Research Support as Topic
1
2020
6
0.840
Why?
Accreditation
1
2019
2
0.820
Why?
Electrodiagnosis
1
2019
4
0.820
Why?
Pediatrics
2
2020
192
0.820
Why?
Referral and Consultation
1
2019
33
0.800
Why?
Practice Patterns, Physicians'
1
2020
85
0.790
Why?
Drug Delivery Systems
1
2019
5
0.790
Why?
Precision Medicine
1
2019
34
0.760
Why?
Retrospective Studies
6
2022
1105
0.730
Why?
Arteriovenous Malformations
1
2015
1
0.600
Why?
Cervical Vertebrae
1
2015
4
0.600
Why?
Spinal Cord
1
2015
4
0.600
Why?
Thoracic Vertebrae
1
2015
4
0.600
Why?
Physical Therapy Modalities
1
2014
4
0.570
Why?
Probability
1
2014
17
0.560
Why?
Models, Statistical
1
2014
29
0.560
Why?
Adolescent
4
2022
1938
0.440
Why?
United States
3
2021
594
0.390
Why?
Administration, Oral
2
2020
64
0.390
Why?
Female
5
2021
3314
0.350
Why?
Genetic Variation
2
2019
142
0.340
Why?
Young Adult
4
2021
573
0.320
Why?
Child, Preschool
3
2021
1479
0.310
Why?
Infant
3
2021
1365
0.290
Why?
Male
4
2021
3249
0.270
Why?
Immunization
1
2022
21
0.240
Why?
Vaccination
1
2022
30
0.240
Why?
Radiotherapy, Image-Guided
1
2021
1
0.230
Why?
Brain Injuries
1
2021
8
0.230
Why?
Motor Disorders
1
2021
2
0.230
Why?
Cognition Disorders
1
2021
14
0.230
Why?
Appointments and Schedules
1
2021
13
0.220
Why?
Ambulatory Care Facilities
1
2021
29
0.220
Why?
Disability Evaluation
1
2020
7
0.220
Why?
Tomography, X-Ray Computed
1
2021
116
0.210
Why?
Atmospheric Pressure
1
2020
1
0.210
Why?
Personal Protective Equipment
1
2020
1
0.210
Why?
Hydroxychloroquine
1
2020
1
0.210
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
1
0.210
Why?
Adenosine Monophosphate
1
2020
2
0.210
Why?
Alanine
1
2020
3
0.210
Why?
Public-Private Sector Partnerships
1
2020
2
0.210
Why?
Metabolome
1
2020
5
0.210
Why?
Off-Label Use
1
2020
5
0.210
Why?
Injections, Intramuscular
1
2020
5
0.210
Why?
Antimalarials
1
2020
5
0.210
Why?
Vulnerable Populations
1
2020
5
0.210
Why?
Tandem Mass Spectrometry
1
2020
19
0.210
Why?
Body Weight
1
2020
60
0.210
Why?
Drug Administration Schedule
1
2020
45
0.210
Why?
Antiviral Agents
1
2020
22
0.210
Why?
Muscles
1
2019
2
0.210
Why?
Case-Control Studies
1
2020
119
0.200
Why?
Patient Selection
1
2020
46
0.200
Why?
Missouri
1
2019
90
0.200
Why?
Molecular Targeted Therapy
1
2019
11
0.200
Why?
Cross-Sectional Studies
1
2020
263
0.200
Why?
Research Design
1
2019
55
0.190
Why?
Age Factors
1
2019
227
0.180
Why?
Sulfonylurea Receptors
1
2017
3
0.180
Why?
Pharmacological Phenomena
1
2017
1
0.180
Why?
Pharmacokinetics
1
2017
14
0.170
Why?
Prognosis
1
2017
180
0.170
Why?
Polymorphism, Single Nucleotide
1
2017
205
0.160
Why?
Quadriplegia
1
2015
1
0.150
Why?
Magnetic Resonance Imaging
1
2015
81
0.140
Why?
Recovery of Function
2
2021
16
0.120
Why?
Rehabilitation Centers
1
2021
2
0.060
Why?
Endosonography
1
2021
1
0.060
Why?
Fiducial Markers
1
2021
1
0.060
Why?
Needles
1
2021
3
0.060
Why?
Cognition
1
2021
28
0.060
Why?
Inpatients
1
2021
44
0.060
Why?
Predictive Value of Tests
1
2021
101
0.060
Why?
Cohort Studies
1
2021
250
0.050
Why?
Calibration
1
2020
6
0.050
Why?
Stereoisomerism
1
2020
9
0.050
Why?
Chromatography, Liquid
1
2020
10
0.050
Why?
Length of Stay
1
2021
220
0.050
Why?
Drug Monitoring
1
2020
20
0.050
Why?
Prospective Studies
1
2021
458
0.050
Why?
Hospitalization
1
2021
157
0.050
Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
25
0.040
Why?
McLaughlin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_